Fresenius pushes further into generics

Monday, May 1, 2017 - 00:11 in Mathematics & Economics

German firm to acquire U.S. generics maker Akorn and Merck KGaA’s biosimilars business

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net